GRISENDI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 11.686
EU - Europa 5.512
AS - Asia 4.395
SA - Sud America 705
AF - Africa 69
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.408
Nazione #
US - Stati Uniti d'America 11.527
IT - Italia 1.802
SG - Singapore 1.497
GB - Regno Unito 1.339
CN - Cina 1.337
HK - Hong Kong 616
SE - Svezia 569
BR - Brasile 556
DE - Germania 533
VN - Vietnam 303
RU - Federazione Russa 299
UA - Ucraina 162
FI - Finlandia 152
FR - Francia 151
TR - Turchia 138
ID - Indonesia 136
CA - Canada 82
KR - Corea 82
BG - Bulgaria 79
NL - Olanda 74
AR - Argentina 65
IN - India 64
BE - Belgio 52
IE - Irlanda 52
MX - Messico 51
JP - Giappone 48
PL - Polonia 45
ES - Italia 41
AU - Australia 34
ZA - Sudafrica 32
BD - Bangladesh 28
EC - Ecuador 25
AL - Albania 21
CZ - Repubblica Ceca 21
AT - Austria 20
LT - Lituania 19
CH - Svizzera 18
MY - Malesia 15
RO - Romania 15
IQ - Iraq 14
VE - Venezuela 14
IR - Iran 13
BZ - Belize 12
IL - Israele 11
MA - Marocco 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 9
CL - Cile 9
CO - Colombia 9
PE - Perù 9
JO - Giordania 8
PK - Pakistan 8
PT - Portogallo 8
KE - Kenya 7
MD - Moldavia 7
NP - Nepal 6
OM - Oman 6
PY - Paraguay 6
UY - Uruguay 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
GR - Grecia 5
KZ - Kazakistan 5
MT - Malta 5
RS - Serbia 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
PH - Filippine 4
DK - Danimarca 3
EE - Estonia 3
LB - Libano 3
LK - Sri Lanka 3
NG - Nigeria 3
PA - Panama 3
SI - Slovenia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CY - Cipro 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
GA - Gabon 1
GU - Guam 1
Totale 22.391
Città #
Fairfield 1.345
Ashburn 1.172
Santa Clara 1.161
Singapore 1.033
Southend 798
Chandler 745
Woodbridge 696
Houston 610
Hong Kong 602
Seattle 478
Cambridge 437
Ann Arbor 422
Wilmington 420
Nyköping 346
Hefei 328
Modena 287
London 268
Dearborn 262
Jacksonville 251
Beijing 242
Los Angeles 221
New York 221
Bologna 193
Chicago 141
Munich 135
San Diego 129
Milan 119
Jakarta 118
Ho Chi Minh City 105
Shanghai 96
Helsinki 88
Frankfurt am Main 85
Princeton 84
Izmir 77
Sofia 77
Moscow 75
Seoul 75
Hanoi 69
The Dalles 68
Parma 66
Fremont 63
Eugene 58
Council Bluffs 57
Buffalo 54
Dallas 54
São Paulo 52
Boardman 48
Brussels 48
Dublin 48
Salt Lake City 48
Rome 43
Bremen 42
Phoenix 38
Guangzhou 35
Reggio Emilia 35
Tokyo 33
Warsaw 33
Nuremberg 32
San Giuliano Milanese 31
Columbus 30
Falls Church 30
Orem 30
Atlanta 27
Denver 27
Redwood City 26
Stockholm 26
Elk Grove Village 23
Grafing 23
Montreal 23
Poplar 23
Tampa 23
Johannesburg 22
Brooklyn 21
Lancaster 21
Ravenna 21
Redondo Beach 21
Des Moines 20
Hillsboro 20
Mexico City 20
Norwalk 20
Portsmouth 20
Rio de Janeiro 20
Amsterdam 18
Boston 18
San Francisco 18
Sydney 18
Turku 18
Chennai 17
Dong Ket 16
Tirana 16
Brno 15
Florence 15
Kunming 15
Mumbai 15
Toronto 15
Changsha 14
Ferrara 14
Haiphong 14
Lauterbourg 14
Ottawa 14
Totale 15.818
Nome #
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish 448
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 423
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 422
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 385
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 383
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 381
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 376
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 371
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 353
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 352
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 348
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 330
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 326
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 323
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 317
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 314
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 313
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 308
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro 302
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 300
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 297
Tumor Stroma Manipulation By MSC 296
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 295
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 293
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 292
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 290
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 288
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 272
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 269
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 267
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 262
GD2 CAR T cells against human glioblastoma 262
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 260
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 253
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 251
Detection of microparticles from human red blood cells by multiparametric flow cytometry 247
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 244
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 244
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 243
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 239
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 238
An adoptive immuno-gene therapy approach targeting neuroblastoma. 237
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 233
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 232
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 232
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 232
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 230
Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors 224
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 221
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 218
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 215
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 211
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review 211
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 210
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 205
Scleral ossicles as natural biomaterials on which vascular-like network is promoted from Mouse Aortic Endothelial cells (MAECs): preliminary results 202
Cancer stem cells and their microenvironment. 200
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 199
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 197
Challenging the efficacy of checkpoint inhibitors: a new 3D model for a precision medicine approach. 197
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. 197
IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation 196
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 193
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma 193
Sarcomas as a mise en abyme of Mesenchymal Stem Cells; exploiting interrelationships for cell mediated anticancer therapy 193
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 193
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 191
Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis 189
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico 189
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 187
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells 184
Stem cells and lung cancer : between advanced diagnostics and new therapeutics. 184
New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells. 180
Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9) 179
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models 168
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 155
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 150
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 148
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 145
Refining GMP-manufactured density gradient media for optimised mesenchymal stromal/stem cell isolation and expansion. 143
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine 143
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance 141
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 140
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study 140
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 139
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 133
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence 132
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 131
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 125
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro 125
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 124
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 109
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 105
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy 103
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 101
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 94
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 85
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations 80
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study 76
IFN-β expression is directly activated in human neutrophils transfected with plasmid DNA and is further increased via TLR-4-mediated signaling 66
Totale 22.632
Categoria #
all - tutte 89.639
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.639


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.612 0 0 0 0 0 181 146 253 175 422 305 130
2021/20222.303 106 321 233 90 78 123 177 145 216 163 414 237
2022/20232.267 259 278 189 241 231 265 63 216 260 26 124 115
2023/20241.494 101 88 113 155 280 181 102 138 36 51 71 178
2024/20255.067 144 90 184 372 850 859 501 263 527 254 402 621
2025/20264.689 633 332 669 1.134 1.592 329 0 0 0 0 0 0
Totale 22.694